Om P Ganda

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes
    Om P Ganda
    Adult Diabetes and Clinical Research, Joslin Diabetes Center, Harvard Medical School, 1 Joslin Place, Boston, MA, 02215, USA
    Curr Cardiol Rep 18:114. 2016
  2. doi request reprint Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes
    Om P Ganda
    Clinical Research and Adult Diabetes Sections, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA E mail
    Cleve Clin J Med 83:S11-7. 2016
  3. pmc Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia
    O P Ganda
    Sections of Adult Medicine, Clinical Research, and Bioinformatics at Joslin Diabetes Center, and Department of Medicine, Beth Israel Medical Center, and Harvard Medical School, 1, Joslin Place, Rm 242, Boston, MA 02215, United States
    Diabetes Res Clin Pract 97:51-6. 2012
  4. pmc The role of bile acid sequestrants in the management of type 2 diabetes mellitus
    Om P Ganda
    Lipid Clinic, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA
    Metab Syndr Relat Disord 8:S15-21. 2010
  5. doi request reprint Salt sensitivity, insulin resistance, and public health in India
    Om P Ganda
    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Endocr Pract 16:940-4. 2010
  6. doi request reprint Refining lipoprotein assessment in diabetes: apolipoprotein B makes sense
    Om P Ganda
    Section of Adult Medicine, Joslin Diabetes Center, Beth Israel Medical Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA
    Endocr Pract 15:370-6. 2009
  7. ncbi request reprint The role of lipid management in diabetes
    Om P Ganda
    Joslin Diabetes Center, Department of Medicine, Harvard Medical School, One Joslin Place, 242, Boston, MA 02115, USA
    Cardiol Clin 23:153-64, vi. 2005
  8. pmc Look who's (not) talking: diabetic patients' willingness to discuss self-care with physicians
    Elizabeth A Beverly
    Joslin Diabetes Center, Boston, MA, USA
    Diabetes Care 35:1466-72. 2012
  9. pmc Do older adults aged 60-75 years benefit from diabetes behavioral interventions?
    Elizabeth A Beverly
    Joslin Diabetes Center, Boston, Massachusetts, USA
    Diabetes Care 36:1501-6. 2013
  10. pmc Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trial
    Elizabeth A Beverly
    Behavioral Health and Outcomes Research, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes Educ 39:504-14. 2013

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes
    Om P Ganda
    Adult Diabetes and Clinical Research, Joslin Diabetes Center, Harvard Medical School, 1 Joslin Place, Boston, MA, 02215, USA
    Curr Cardiol Rep 18:114. 2016
    ..Until we have these data, perhaps it is time to shift our focus from a rigid blood pressure target to risk-based goals...
  2. doi request reprint Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes
    Om P Ganda
    Clinical Research and Adult Diabetes Sections, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA E mail
    Cleve Clin J Med 83:S11-7. 2016
    ..The CV benefits of one sodium-glucose cotransporter-2 inhibitor reported in an RCT await confirmation in ongoing trials. ..
  3. pmc Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia
    O P Ganda
    Sections of Adult Medicine, Clinical Research, and Bioinformatics at Joslin Diabetes Center, and Department of Medicine, Beth Israel Medical Center, and Harvard Medical School, 1, Joslin Place, Rm 242, Boston, MA 02215, United States
    Diabetes Res Clin Pract 97:51-6. 2012
    ..We assessed the discordance between non-HDL-C and Apo-B targets in patients with diabetes with TG 200-499 mg/dl...
  4. pmc The role of bile acid sequestrants in the management of type 2 diabetes mellitus
    Om P Ganda
    Lipid Clinic, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA
    Metab Syndr Relat Disord 8:S15-21. 2010
    ..Colesevelam HCl is the only drug approved for this dual indication and is an adjunct in the treatment of both hyperglycemia and hypercholesterolemia that frequently co-exist in adults with T2DM...
  5. doi request reprint Salt sensitivity, insulin resistance, and public health in India
    Om P Ganda
    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Endocr Pract 16:940-4. 2010
    ..To provide a current overview of the worldwide prevalence and pattern of cardiovascular disease and discuss the role of sodium intake and salt sensitivity, with a focus on the Asian Indian population...
  6. doi request reprint Refining lipoprotein assessment in diabetes: apolipoprotein B makes sense
    Om P Ganda
    Section of Adult Medicine, Joslin Diabetes Center, Beth Israel Medical Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA
    Endocr Pract 15:370-6. 2009
    ..To summarize the data that support the measurement of apolipoprotein B as an accurate reflection of low-density lipoprotein (LDL) particle number and an easily adapted parameter in clinical practice...
  7. ncbi request reprint The role of lipid management in diabetes
    Om P Ganda
    Joslin Diabetes Center, Department of Medicine, Harvard Medical School, One Joslin Place, 242, Boston, MA 02115, USA
    Cardiol Clin 23:153-64, vi. 2005
    ..This article discusses the role of lipid management in diabetes...
  8. pmc Look who's (not) talking: diabetic patients' willingness to discuss self-care with physicians
    Elizabeth A Beverly
    Joslin Diabetes Center, Boston, MA, USA
    Diabetes Care 35:1466-72. 2012
    ..Effective physician-patient communication improves glycemia and diabetes self-care; however, communication gaps may exist that prevent patients from discussing self-care problems with treatment providers...
  9. pmc Do older adults aged 60-75 years benefit from diabetes behavioral interventions?
    Elizabeth A Beverly
    Joslin Diabetes Center, Boston, Massachusetts, USA
    Diabetes Care 36:1501-6. 2013
    ..Seventy-one community-dwelling older adults and 151 younger adults were randomized to attend a structured behavioral group, an attention control group, or one-to-one education...
  10. pmc Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trial
    Elizabeth A Beverly
    Behavioral Health and Outcomes Research, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes Educ 39:504-14. 2013
    ..The purpose of the study was to assess the value of reinforcing diabetes self-management for improving glycemia and self-care among adults with type 2 diabetes who had at least 3 hours of prior diabetes education...
  11. pmc The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial
    Katie Weinger
    Behavioral Health and Outcomes Research, Joslin Diabetes Center, Boston, MA 02215, USA
    Arch Intern Med 171:1990-9. 2011
    ..The best methods to support patients as they follow diabetes prescriptions and recommendations are unclear...
  12. ncbi request reprint Ask the doctor. I have been taking niacin for several years, and it has helped keep my good and bad cholesterol in their healthy ranges. Now I have been diagnosed with diabetes, and my doctor forbids me from taking niacin any more. What's the reasoning be
    Om P Ganda
    Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
    Harv Heart Lett 16:8. 2006
  13. ncbi request reprint Insulin resistance syndrome: implications for the Asian American population
    Om P Ganda
    Endocr Pract 9:31-4. 2003
  14. ncbi request reprint American College of Endocrinology position statement on the insulin resistance syndrome
    Daniel Einhorn
    American College of Endocrinology
    Endocr Pract 9:237-52. 2003
  15. ncbi request reprint Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial
    Scott M Grundy
    The University of Texas Southwestern Medical Center, Room Y3206, 5323 Harry Hines Blvd, Dallas, TX 75390 9052
    Arch Intern Med 162:1568-76. 2002
    ..We evaluated the efficacy and safety of once-daily extended-release (ER) niacin in patients with diabetic dyslipidemia...